The current temperature: A survey of post-resuscitation care across Australian and New Zealand intensive care units

The role of targeted temperature management in 30-day hospital readmissions in cardiac arrest survivors: A national population-based study

“…First, there is higher perceived benefit of instituting TTM in shockable rhythms over non-shockable rhythms as was identified in the HACA trial [5] , while further trials extend its benefit to non-shockable rhythms for in- and out-of-hospital cardiac arrest, however emphasizing neurologic outcomes rather than readmissions [27] . Second, healthcare system-based challenges may limit timely TTM implementation in patients whose clinical presentation supports TTM initiation [9] , [10] , [11] , [12] , [13] , [14] , [15] . Third, the literature identifies variability in TTM temperature targets based on initial cardiac arrest rhythm [9] , [10] , [11] , [12] .…”

“…Furthermore, adherence to specific temperature targets has declined since the publication of the TTM trial [9] , [10] , [11] , [12] . Additionally, the decision to initiate TTM continues to be largely influenced by patient demographics, clinician uncertainty and varying adherence to protocols, availability of cooling devices at home institutions, and arrest circumstances [9] , [10] , [11] , [12] , [13] , [14] , [15] .…”

Opinions and attitudes toward targeted temperature management in the emergency department and intensive care unit in a developing country: a survey study

“…Alarmingly, out-of-hospital cardiac arrest mortality was trending down the decade preceding the publication of the TTM 1 trial but increased for the first time in the years following. [18] This is possibly due to the misinterpretation of the TTM 1 trial as a negative study and an abandonment of this treatment altogether. [18] A growing body of evidence shows a significant decrease in TTM administration following the TTM 1 trial.…”

“…[18] This is possibly due to the misinterpretation of the TTM 1 trial as a negative study and an abandonment of this treatment altogether. [18] A growing body of evidence shows a significant decrease in TTM administration following the TTM 1 trial. [19] The majority of participants in this study were emergency department staff (65.3%).…”

“…The questionnaire consisted of multiple-choice questions (supplementary material). Questions were derived from the findings of World J Emerg Med 2023;14(2):138-142 DOI: 10.5847/wjem.j.1920-8642.2023.030 previous literature, [18] in addition to expert consensus in emergency medicine and critical care medicine. Before releasing the survey, the questionnaire was piloted on residents and faculty for face validity.…”